Mark Pruzanski serves as Executive at INTERCEPT PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Mark Pruzanski has executed 201 insider transactions totaling $60.3M, demonstrating a bearish approach to their equity position. Their most recent transaction on Apr 9, 2013 involved exercising options for 24,339 shares valued at $0.
Mark Pruzanski currently holds 618,894 shares of INTERCEPT PHARMACEUTICALS INC (ICPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Pruzanski has been a net seller of ICPT stock. They have purchased $500.0K and sold $59.8M worth of shares.
Mark Pruzanski's most recent insider trade was on Apr 9, 2013, when they sold 24,339 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted